X

Immuno-Oncology News

Immuno-Oncology News
Post-surgery Opdivo Shows Benefits for Esophageal, GEJ Cancer Patients in Ongoing Trial
Immuno-Oncology News
EMA to Review Opdivo-Yervoy Combo for Untreated, Inoperable Mesothelioma
Immuno-Oncology News
FDA Acts to Speed Toripalimab as Potential Nasopharyngeal Cancer Treatment
Immuno-Oncology News
EU Approval Recommended for Opdivo-Yervoy-Chemo Combo for Advanced NSCLC
Immuno-Oncology News
Tecentriq-Avastin Combo Recommended for EU Approval for Liver Cancer
Immuno-Oncology News
First-line Keytruda Doubles 5-Year Survival in Certain Lung Cancer Patients, Data Show
Immuno-Oncology News
Keytruda Combo Shown to Extend Survival in Advanced Esophageal, GEJ Cancers
Immuno-Oncology News
Libtayo First-line Treatment Prolongs Survival in Advanced NSCLC, Early Trial Data Show
Immuno-Oncology News
Strong Response for Tessa’s CD30 CAR-T Cell Therapy in Hodgkin’s Lymphoma Trial
Immuno-Oncology News
Subscribe to Immuno-Oncology News

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
#575662
#a60538
#49cde9
#c20fce
#d95d39
#eb5834